Correlation Between Hookipa Pharma and Oncternal Therapeutics
Can any of the company-specific risk be diversified away by investing in both Hookipa Pharma and Oncternal Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hookipa Pharma and Oncternal Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hookipa Pharma and Oncternal Therapeutics, you can compare the effects of market volatilities on Hookipa Pharma and Oncternal Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hookipa Pharma with a short position of Oncternal Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hookipa Pharma and Oncternal Therapeutics.
Diversification Opportunities for Hookipa Pharma and Oncternal Therapeutics
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Hookipa and Oncternal is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Hookipa Pharma and Oncternal Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oncternal Therapeutics and Hookipa Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hookipa Pharma are associated (or correlated) with Oncternal Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oncternal Therapeutics has no effect on the direction of Hookipa Pharma i.e., Hookipa Pharma and Oncternal Therapeutics go up and down completely randomly.
Pair Corralation between Hookipa Pharma and Oncternal Therapeutics
Given the investment horizon of 90 days Hookipa Pharma is expected to generate 0.77 times more return on investment than Oncternal Therapeutics. However, Hookipa Pharma is 1.3 times less risky than Oncternal Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Oncternal Therapeutics is currently generating about -0.04 per unit of risk. If you would invest 950.00 in Hookipa Pharma on August 24, 2024 and sell it today you would lose (735.00) from holding Hookipa Pharma or give up 77.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hookipa Pharma vs. Oncternal Therapeutics
Performance |
| Timeline |
| Hookipa Pharma |
| Oncternal Therapeutics |
Hookipa Pharma and Oncternal Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hookipa Pharma and Oncternal Therapeutics
The main advantage of trading using opposite Hookipa Pharma and Oncternal Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hookipa Pharma position performs unexpectedly, Oncternal Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oncternal Therapeutics will offset losses from the drop in Oncternal Therapeutics' long position.| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
| Oncternal Therapeutics vs. Lyra Therapeutics | Oncternal Therapeutics vs. Hookipa Pharma | Oncternal Therapeutics vs. Cingulate Warrants | Oncternal Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |